Research two businesses currently supplying medical devices on the market. Describe how they defer from each other including type of corporation, size, and finances. Also describe a similarity like type of product or marketing strategy.
Two well-known medical device companies are Medtronic and Stryker. Medtronic's market cap is $168.59 billion and Stryker's is $99.43 billion. Therefore, both are massive companies in the space and each dominate their niche, respectively. In the case of Medtronic, they are known for producing medical devices used for diabetes. Some of the products they produce are insulin pumps, pacemakers and other cardiac devices. In contrast Stryker deals with orthopedic devices and devices related to the spine and its relation to the neural-connectivity to the brain. Both of these companies are publicly traded and are quite large, their marketing strategy involves creating partnerships with hospitals, doctors, and institutions.
Company |
Size |
Finances |
Stryker |
43,000 employees |
$ 4 Billion |
GE Healthcare |
54,000 employees |
$ 18 Billion |
Stryker- is one of the world’s leading medical technology companies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes.
GE Healthcare- is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. By deploying AI and automated workflows on their devices like their ultrasound devices, clinicians have built-in assistance when viewing high-quality images of areas of the body such as the heart and lung.
Company (net worth)
Johnson & Johnson (26 billion)
Johnson & Johnson took the second spot in 2020. Johnson & Johnson’s Medical Devices segment includes a wide range of products used in the Orthopaedic, Surgery, Interventional Solutions and Eye Health fields. In 2019, the division generated sales of $26billion, a decrease of 4% compared to 2018. A fall in sales for the division was as a result of a decline in revenue for Surgery and Orthopaedics. A further decrease in growth was offset by a stellar performance for Electrophysiology, Contact Lens and Energy and Endocutters. Looking ahead, the company plans to prioritise improving their pipeline of innovation and managing their portfolio by focusing on the smooth execution of acquisitions and strategic partnerships. J&J has 130,000 employees.
Boston Scientific is multinational biomedical cooperation with 11.91 billion in revenue and 41000 employees as of 2021. They specialize in making devices and providing solutions in interventional radiology, interventional cardiology, peripheral interventions, and neuromodulation.
Siemens Healthineers is a Germany-based Multinational Corporation with 18 billion in revenue and 66000 employees. They specialize in medical technologies, particularly in devices and imaging such as X-rays, CT scans, Ultrasounds, MRI, and radiation oncology. Siemens Healthineers has also acquired different companies worldwide in molecular diagnostics, robotics, and point-of-care diagnostics.
Both companies have partnered with medical institutions, doctors and health service providers and quite aggressively marketed products. Although Siemens is able to mass produce devices in local Asiatic market and has virtually controlled south Asian hospital market. On other hand Boston Scientific is much across United States and parts of Europe and have made impact particularly in field of implants, micro and macro monitoring devices and critical care products.
Intuitive Surgical, Inc
Intuitive Surgical is an American corporation the focuses on the production of surgical robots that are able to assist surgeons conducting surgery while in the operating room. Intuitive Surgical is a Corporation that operates in America as mentioned previously. I was not able to find on the Internet whether the company is a c-corp or an s-corp, however, through the lecture we learned that S-Corp corporations cannot be publicly traded while Intuitive Surgical is publicly traded, therefore it would be a C-Corp Corporation. As of December 2021 Intuitive Surgical has 9,793 employees and as of 2021 it had a revenue of 5.71 billion USD. This company prides itself on developing and producing surgical robots that are able to conduct minimally invasive procedures with higher success rates than with the surgeon working on their own.
Asensus Surgical
Previously known as TransEnterix, Asensus Inc is an American based corporation that specializes in bridging the gap between surgery and robotics. Similarly, to Intuitive, I could not find what type of corporation this is but seeing it being publicly traded means that it is also an S-Corp Corporation. As of 2021 the company had brought in a revenue of 8.23M dollars with a work force of 167 employees for that year. This particular company’s main focus is providing more technology in the operating room for the doctors to help minimize error during operations. Asensus prides itself on implementing augmented reality in to their robots that would help assist the user when conducting a procedure.
Both of these companies are in the space of developing surgical robots that are meant to be used in the operating room and assisting the doctors. Intuitive Surgical is a vastly larger company than Asensus and their marketing strategies are different. Intuitive is best known for their Da Vinci Surgical robot and have advertised it as so effective that it can suture together a grape that has had its skin peeled off. Asensus takes a different approach where they try to make the actual of act of conducting a procedure much easier by helping the surgeon guide the tools as well providing recommendations on how to operate with their augmented reality technology.
Two businesses currently supplying medical devices on the market include Medtronic and Getinge. Medtronic is a publicly traded company with about 95,000 employees across the globe. In 2023, Medtronic's reported revenue was $31.227 billion. Similarly, Getinge is also a global, publicly traded company, but operates on a much smaller scale, with 10,000 employees. In 2023, Getinge reported their revenue as $3.03 billion.
In terms of their products, Medtronic and Getinge differ in their respective specializations in medical devices. Medtronic operates across a variety of categories of medical devices, including, but not limited to, those supporting diabetes management, cardiovascular health, and minimally invasive surgeries. The company's products are extremely diverse, making Medtronic and dominating entity in many medical device applications. Getinge, however, focuses their production primarily on devices related to cardiovascular procedures, operating rooms, and intensive care.
The two U.S.-based companies I reviewed are Zimmer Biomet Holdings, Inc. and Integra LifeSciences Corporation. They both supply surgical medical devices for spine and orthopedic conditions on the market but differ in corporate structure, size, and finances. They have similar marketing strategies through their advertising as well as through partnerships with medical centers and hospitals due to the fact that they are targeting similar conditions in patients.
Zimmer Biomet Holdings, Inc.
- Type of Corporation: Zimmer Biomet is a publicly traded company (NYSE: ZBH).
- Size: Zimmer Biomet is a large-cap corporation with over 19,000 employees. In 2023, the company generated more than $7 billion in revenue.
- Products: Zimmer Biomet primarily focuses on orthopedic products such as joint replacement systems (hip, knee, shoulder) and surgical products for spinal injuries and sports medicine.
- Marketing Strategy: Zimmer Biomet targets hospitals, surgical centers, and healthcare professionals, using a combination of direct sales and distributors. They invest heavily in physician education programs, patient outreach, and digital marketing platforms to promote their products.
Integra LifeSciences Corporation
- Type of Corporation: Integra LifeSciences is also a publicly traded company (NASDAQ: IART).
- Size: Integra LifeSciences is a mid-cap company with approximately 4,500 employees. It reported $1.6 billion in revenue in 2023.
- Products: Integra specializes in neuro, spinal, and tissue repair products, such as nerve repair technologies, wound healing devices, and spinal fusion hardware. While the product categories are different from Zimmer Biomet, both companies focus on advanced surgical solutions.
- Marketing Strategy: Integra also targets hospitals, surgeons, and healthcare systems but places a particular emphasis on collaborating with leading surgeons and scientific research. They use key opinion leaders (KOLs) in neurosurgery and wound care to promote their devices and highlight clinical success stories.